Home LiteratureArticle Details
PMID: 2985995 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.

The New England journal of medicine ·Vol. 312 ·No. 22 ·1985-05-30 ·Pages 1405-11

Hafler DA, Fox DA, Manning ME, Schlossman SF, Reinherz EL, Weiner HL

Abstract

We found an increase in peripheral-blood lymphocytes bearing the T-cell-specific activation antigen Ta1 in 20 of 35 patients with progressive multiple sclerosis, 4 of 18 patients with stable or improving multiple sclerosis, 1 of 17 patients with other neurologic diseases, and 1 of 14 normal controls (P less than 0.0002, Fisher's exact test). No increases in two other markers of T-cell activation, T113 and the interleukin-2 receptor, were found. In the cerebrospinal fluid, patients with progressive multiple sclerosis (pleocytosis, 3.9 +/- 1.6 cells per cubic millimeter) had 42 +/- 3.0 per cent Ta1+ cells. In contrast, patients with other inflammatory central nervous system diseases (36 +/- 13 cells per cubic millimeter) had 9.6 +/- 1.8 per cent Ta1+ cells (P less than 0.01). In patients with other neurologic diseases without inflammation (0.7 +/- 0.16 cells per cubic millimeter), the percentage of Ta1+ cells was equivalent to that in patients with multiple sclerosis (39 +/- 5.4 per cent), although the absolute number was lower. There was a positive correlation between the presence of Ta1+ cells in the spinal fluid and blood of patients with other neurologic diseases, but not patients with multiple sclerosis. Less than 1 per cent of lymphocytes from the spinal fluid of patients with multiple sclerosis expressed interleukin-2 receptors, as compared with 9.8 per cent of cells from subjects with other inflammatory neurologic diseases (P less than 0.01). These results suggest that the T cells in the spinal fluid of patients with multiple sclerosis may be activated by a different mechanism or in a different temporal sequence from that in patients with other nervous system diseases. Furthermore, the increase in Ta1+ cells in the peripheral blood of patients with multiple sclerosis demonstrates systemic immune activation in the disease; monitoring such cells may provide an objective measure of abnormal immunologic activity.

MeSH Terms
Adolescent Adult Aged Antibodies, Monoclonal/immunology Antigens, Surface/immunology Female Humans Lymphocyte Activation Male Middle Aged Multiple Sclerosis/cerebrospinal fluid,immunology T-Lymphocytes/immunology Tumor Necrosis Factor Receptor Superfamily, Member 7
Chemicals
Antibodies, Monoclonal Antigens, Surface Tumor Necrosis Factor Receptor Superfamily, Member 7
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Hafler D A
Fox D A
Manning M E
Schlossman S F
Reinherz E L
Weiner H L
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
0028-4793
Published
1985-05-30
Pages
1405-11
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Grants
NIAID NIH HHS · AI 12069 · United States
NIAID NIH HHS · AI 19807 · United States
NINDS NIH HHS · NS 17182 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com